Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents.
Battin C, De Sousa Linhares A, Leitner J, Grossmann A, Lupinek D, Izadi S, Castilho A, Waidhofer-Söllner P, Grabmeier-Pfistershammer K, Stritzker J, Steinberger P.
Battin C, et al.
Cancer Immunol Immunother. 2023 Sep;72(9):3029-3043. doi: 10.1007/s00262-023-03474-8. Epub 2023 Jun 13.
Cancer Immunol Immunother. 2023.
PMID: 37310433
Free PMC article.